arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Heartflow, Inc.

HTFL
$51.93 ▼ -4.67 (-8.25%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
12 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Heartflow, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.5B
Dividend Yield —
Revenue Growth 47.6% ↗
Op. Margin -27.9% ↗
ROIC -6.4% ↗
FCF / Share $-0.12 ↗
Trailing P/E —
Price / Book 16.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

12-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$64.08M
↑ +47.6% —
Net Income Profit after all expenses
$-27.38M
↑ +15.4% —
Operating Margin Operating profit as % of sales
-27.9%
↑ +50.2% 7th
FCF / Share Free cash flow per share
$-0.12
↑ +97.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑
6
Returns
20
Financial Health ↓
33
Cash Quality ↓
40

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 12 quarters